Clinical Utilities of Serum and Urinary Desmosine as a Prognosis and Efficacy Biomarker for Cystic Fibrosis

StatusFinished
Effective start/end date1/05/1330/06/13

Funding

  • University of Minnesota (BMDA-039): £15,499.00